Peri Jonathan
Transaction: 08/10/2026
OTHER
Change
0
Price
Not reported
Filing
08/14/2026
Type
OTHER
Citius Oncology, Inc.
CTOR • Medical - Pharmaceuticals
$0.67
▼ -0.04 (-5.55%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 62%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$72.39M
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Manageable debt level · 0.08Weak liquidity · 0.56Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 20, 2026, 12:15 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.67
Change-5.55%
Shares Out107.89M
Market Cap$72.39M
Enterprise Value$66.04M
52W Range0.49 - 2.25
Beta3.49
P/E-1.57
P/S10.19
P/B1.79
P/FCF-3.67
EV/Sales9.29
Price$0.67
Change-5.55%
Shares Out107.89M
Market Cap$72.39M
Enterprise Value$66.04M
52W Range0.49 - 2.25
Beta3.49
P/E-1.57
P/S10.19
P/B1.79
P/FCF-3.67
EV/Sales9.29
EV/EBITDA-1.47
EV/FCF-3.35
Earnings Yield-63.63%
FCF Yield-27.22%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.08
Current Ratio0.56
Quick Ratio0.11
Target$6.00
Target Upside794.19%
Target Median$6.00
Target Range6.00 - 6.00
Volume58.01K
Avg Volume93.36K
EPS Surprise-0.26
Investment DNA
How strong this company looks for long-term investors
42
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
39/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
76/100
Why this score▼
Manageable debt level · 0.08Weak liquidity · 0.56Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 2 analyst votes · 2026-10-21
100/100
Bullish
Bullish
2
Hold
0
Bearish
0
Price Target
2026-08-20
Low
$6.00
Mean
$6.00
Median
$6.00
High
$6.00
Insider Transactions
Recent executive and insider activity
Holuka Eugene Myron
Transaction: 09/19/2025
BUY
Change
+300,000
Price
Not reported
Filing
09/23/2025
Type
BUY
Dutia Suren G
Transaction: 09/19/2025
BUY
Change
+300,000
Price
Not reported
Filing
09/23/2025
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Peri Jonathan | OTHER | 0 | Not reported | 08/10/2026 | 08/14/2026 |
| Holuka Eugene Myron | BUY | +300,000 | Not reported | 09/19/2025 | 09/23/2025 |
| Dutia Suren G | BUY | +300,000 | Not reported | 09/19/2025 | 09/23/2025 |
| Mayersohn Joel David | BUY | +300,000 | Not reported | 09/19/2025 | 09/23/2025 |
| Bartushak Jaime | BUY | +825,000 | Not reported | 09/19/2025 | 09/23/2025 |
| MCGRATH DENNIS M | BUY | +300,000 | Not reported | 09/19/2025 | 09/23/2025 |
| Czuczman Myron | BUY | +825,000 | Not reported | 09/19/2025 | 09/23/2025 |
| Webb Carol | BUY | +300,000 | Not reported | 09/19/2025 | 09/23/2025 |
| Mazur Leonard L | BUY | +1,700,000 | Not reported | 09/19/2025 | 09/23/2025 |
| Smith Robert Joseph | BUY | +300,000 | Not reported | 09/19/2025 | 09/23/2025 |
| HOLUBIAK MYRON Z | BUY | +100,000 | Not reported | 09/19/2025 | 09/23/2025 |
| Mayersohn Joel David | BUY | +21,228 | Not reported | 07/28/2025 | 08/07/2025 |
| Czuczman Myron | BUY | +400,000 | $1.07 | 12/12/2024 | 12/16/2024 |
| Mazur Leonard L | BUY | +800,000 | $1.07 | 12/12/2024 | 12/16/2024 |
| Bartushak Jaime | BUY | +400,000 | $1.07 | 12/12/2024 | 12/16/2024 |
| MCGRATH DENNIS M | BUY | +125,000 | $1.07 | 12/12/2024 | 12/16/2024 |
| Dutia Suren G | BUY | +125,000 | $1.07 | 12/12/2024 | 12/16/2024 |
| Webb Carol | BUY | +125,000 | $1.07 | 12/12/2024 | 12/16/2024 |
| Smith Robert Joseph | BUY | +125,000 | $1.07 | 12/12/2024 | 12/16/2024 |
| HOLUBIAK MYRON Z | BUY | +50,000 | $1.07 | 12/12/2024 | 12/16/2024 |